Employment AgreementEmployment Agreement • September 16th, 2013 • Medgenics, Inc. • Biological products, (no disgnostic substances) • Pennsylvania
Contract Type FiledSeptember 16th, 2013 Company Industry JurisdictionThis Employment Agreement is made and entered into effective September 13, 2013 (the “Effective Date”), by and between Medgenics, Inc., a Delaware corporation, and John Leaman. As used in this Agreement, capitalized terms have the meanings set forth in Section 20.
September 13, 2013Separation Agreement • September 16th, 2013 • Medgenics, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledSeptember 16th, 2013 Company IndustryThis letter, upon your signature and as of the date of your signature, will constitute the agreement between you and Medgenics, Inc., a Delaware corporation (“Medgenics”), and Medgenics Medical Israel Ltd., a company organized under the laws of the State of Israel (“MMI”), on each of their behalf and on behalf of their respective successors assigns, representatives, officers, agents attorneys, fiduciaries, administrators, directors, and employees (hereinafter MMI and Medgenics shall sometimes be collectively referred to as the “Company”), on the terms of your separation from employment with MMI and, more generally, engagement, with the Company and the termination of that certain Amended and Restated Personal Employment Agreement dated June 1, 2007 among you, Medgenics and MMI, as amended by First Amendment to Amended and Restated Personal Employment Agreement dated June 1, 2008 among you, Medgenics and MMI (hereinafter collectively referred to as the “Employment Agreement”). You and th
CONSULTING SERVICES AGREEMENTConsulting Services Agreement • September 16th, 2013 • Medgenics, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledSeptember 16th, 2013 Company IndustryThis Consulting Services Agreement (“Agreement”) is made as of September 13, 2013 (“Effective Date”) by and between Medgenics, Inc., a Delaware corporation (the “Company”), and Andrew L. Pearlman.